Brean Murray Carret & Co. Upgrades Accretive Health (AH) to Buy; Business Model Outweighs Near-term Delays
Tweet Send to a Friend
Brean Murray Carret & Co. upgraded Accretive Health (NYSE: AH) from Hold to Buy. PT $13 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
